FDA Adverse Event Injury Summary report: N

SROM 28MM +6 M HEAD

MDR report key: 2894064 · Received January 3, 2013

Report

Report Number
1818910-2013-10099
Event Type
Injury
Date Received
January 3, 2013
Date of Event
December 17, 2012
Report Date
December 17, 2012
Manufacturer
DEPUY ORTHOPAEDICS, INC. 1818910
Product Code
JDI
UDI-DI
10603295033165
PMA / PMN Number
K851422
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

PATIENT WAS REVISED TO ADDRESS PAIN AND HIGH SERUM CHROMIUM LEVELS. DOI: (B)(6) 2004; DOR: (B)(6) 2012 (RIGHT HIP). THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. REVIEW OF THE DEVICE HISTORY RECORDS DID NOT REVEAL ANY RELATED MANUFACTURING DEVIATIONS OR ANOMALIES. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A; REV. C. NO ADDITIONAL INFORMATION WAS OBTAINED. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS REGARDING THE REPORTED EVENT. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT OR ADDITIONAL INFORMATION BE RECEIVED TO CHANGE THE OUTCOME OF THE PERFORMED INVESTIGATION, THE COMPLAINT WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THE COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS PAIN AND HIGH SERUM CHROMIUM LEVELS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
3627 SROM 28MM +6 M HEAD S-ROM FEMORAL HEADS (11/13) : HIP METAL FEMORAL HEADS JDI DEPUY ORTHOPAEDICS, INC. 1818910 1365-18-500 YCG40 10603295033165

Patients

Seq Age Sex Outcome Treatment
1 48 YR Female Required Intervention